Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for PAHC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 40.56M
March 31, 2026 40.56M
December 31, 2025 40.53M
September 30, 2025 40.53M
June 30, 2025 40.53M
March 31, 2025 40.53M
December 31, 2024 40.50M
September 30, 2024 40.50M
June 30, 2024 40.50M
March 31, 2024 40.50M
December 31, 2023 40.50M
September 30, 2023 40.50M
June 30, 2023 40.50M
March 31, 2023 40.50M
December 31, 2022 40.50M
September 30, 2022 40.50M
June 30, 2022 40.50M
March 31, 2022 40.50M
December 31, 2021 40.50M
September 30, 2021 40.50M
June 30, 2021 40.50M
March 31, 2021 40.50M
December 31, 2020 40.45M
September 30, 2020 40.45M
June 30, 2020 40.45M
Date Value
March 31, 2020 40.45M
December 31, 2019 40.45M
September 30, 2019 40.45M
June 30, 2019 40.45M
March 31, 2019 40.45M
December 31, 2018 40.39M
September 30, 2018 40.38M
June 30, 2018 40.36M
March 31, 2018 40.32M
December 31, 2017 40.19M
September 30, 2017 40.17M
June 30, 2017 39.88M
March 31, 2017 39.63M
December 31, 2016 39.42M
September 30, 2016 39.41M
June 30, 2016 39.41M
March 31, 2016 39.40M
December 31, 2015 39.24M
September 30, 2015 39.13M
June 30, 2015 39.07M
March 31, 2015 39.01M
December 31, 2014 38.97M
September 30, 2014 38.96M
June 30, 2014 38.79M
March 31, 2014 68.91M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 414.15M
Merck & Co., Inc. 2.469B
ANI Pharmaceuticals, Inc. 22.97M
Corcept Therapeutics, Inc. 107.92M
Veru, Inc. 17.05M